Kenya's Pharmacy and Poisons Board recently intercepted a shipment of malaria drugs containing the active ingredient Artemisinin, considered a substandard treatment for the mosquito-bourne disease. The country's fight against malaria is hindered by the prevalence of counterfeit pharmaceuticals, many of which contain no medicine at all.

Full Story:

Related Summaries